Friends! In this video, I'm going to do a Broadcom stock analysis & discuss the risks and upside potential of AVGO stock
1 extracted signal · 1 resolved · 0 still active
The Patient Investor20 Dec 2025, 00:21 UTC
AI-generated source summary
Broadcom (AVGO) has shown strong revenue growth through acquisitions, with a current price of $329.88. Analysts expect AI chip sales to double, contributing significantly to revenue. The stock's forward P/E ratio is 69, with a 5-year target price of $613.55, suggesting an 89% upside. Oracle (ORCL) faces a more challenging financial situation with high debt and negative free cash flow. The stock is trading at $180.03, down 18% in the past month. Its forward P/E is around 22, significantly lower than AVGO, indicating potential overvaluation concerns, with a price target around $280 for a double in 5 years. However, the current valuation might be fair rather than undervalued.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from The Patient Investor
Why I Don't Own Google Stock & When I'm Buying
The CHEAPEST Quality Stock In The Stock Market!
Intuitive Surgical Stock Analysis! Risks & Upside Potential
There Is NO AI BUBBLE! I’m Buying Every Dip
2 Stocks I'm Buying In The Next 2 Weeks
Netflix Stock Is FINALLY A Buy!
The Patient Investor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
